Page 11 - Gerd Gigerenzer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gerd gigerenzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gerd Gigerenzer Today - Breaking & Trending Today

The Covid-19 pandemic has shown we are risk-illiterate


With a public inquiry examining the UK Government’s handling of the Covid-19 pandemic due to take place in Spring 2022, there is one topic of conversation which has received far less attention than it ought: risk literacy. 
Risk literacy (or rather, illiteracy) has played a far bigger role in this pandemic than many people realise. Whether it be through underestimation or overestimation of risk, many key moments since December 2019 have been affected by people’s risk illiteracy.
Arguably, risk illiteracy throughout this pandemic has been most apparent when it comes to underestimating particular threats, which have resulted in incorrect or late decisions and dire consequences. For example, in early 2020, many people (not just politicians) dismissed Covid-19 as a nasty bout of the flu.  ....

United Kingdom , Alan Foster , Gerd Gigerenzer , Zack Bhalla , Oxford Astrazeneca Covid , World Health Organisation , United Kingdom Government , Swine Flu , ஒன்றுபட்டது கிஂக்டம் , ஆலன் வளர்ப்பு , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஒன்றுபட்டது கிஂக்டம் அரசு , பன்றி காய்ச்சல் ,

Few Would Fear COVID Vaccines if Policy Makers Explained Their Risks Better


Scientific American
Clear messaging and transparency are vital, say some experts on risk assessment and decision-making
Advertisement
Unforeseen safety issues routinely emerge after any new medicine or vaccine goes from testing in tens of thousands of volunteers to actual public use on tens of millions. So it was no major surprise when an extremely small percentage of people developed a strange blood clotting problem after receiving either the Johnson & Johnson (J&J) COVID-19 vaccine or the AstraZeneca shot, which is widely used outside of the U.S.
Rare but dangerous side effects from vaccines can present a tricky dilemma for public health authorities. In this case, the life-threatening blood clots, accompanied by an oddly low count of clot-promoting platelets, appear to strike about two individuals per million people vaccinated with J&J’s shot and about one per 100,000 receiving AstraZeneca’s. Both are minuscule risks, compared with COVID-19 itself, which, by ....

United States , Carnegie Mellon University , United Kingdom , Glen Nowak , Heidij Larson , Paul Offit , Baruch Fischhoff , Gerd Gigerenzer , Rochellep Walensky , Centers For Disease , University Of Potsdam , Drug Administration , University Of Georgia , University Of Cambridge , Harding Center , Washington Post , European Medicines Agency , Winton Center , Vaccine Education Center , Risk Literacy , Disease Control , Risk Communication , Scientific American , Evidence Communication , Vaccine Confidence Project , ஒன்றுபட்டது மாநிலங்களில் ,